MEDXF - Medexus Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

MEDXF is currently covered by 1 analysts

Medexus Pharmaceuticals's activity chart (see below) currently has 0 price targets and 6 ratings on display. The stock rating distribution of MEDXF is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for MEDXF is $1, Lowest price target is $1, average price target is $.

Most recent stock forecast was given by from on 28-Mar-2024.

Best performing analysts who are covering MEDXF - Medexus Pharmaceuticals:

Rahul Sarugaser Justin Keywood David Novak

Currently out of the existing stock ratings of MEDXF, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MEDXF (Medexus Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MEDXF (Medexus Pharmaceuticals) with a proven track record?

RAHUL SARUGASER

Which analyst has the current lower performing score on MEDXF (Medexus Pharmaceuticals) with a proven track record?

DAVID NOVAK

Which analyst has the most public recommendations on MEDXF (Medexus Pharmaceuticals)?

Rahul Sarugaser works at RAYMOND JAMES and has 9 price targets and 8 ratings on MEDXF

Which analyst is the currently most bullish on MEDXF (Medexus Pharmaceuticals)?

David Novak with highest potential upside - $0

Which analyst is the currently most reserved on MEDXF (Medexus Pharmaceuticals)?

Rahul Sarugaser with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?